Noesis Capital Mangement’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-431
Closed -$221K 106
2022
Q4
$221K Buy
+431
New +$219K 0.06% 100

Other funds holding ELV

Noesis Capital Mangement's ELV Position: Q1 2023 in Review

Noesis Capital Mangement sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 431 shares — an estimated $221K sold.

Noesis Capital Mangement first reported a position in ELV in Q4 2022 and held it in 1 quarter. The position peaked at $221K in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Noesis Capital Mangement reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Noesis Capital Mangement sold 431 Elevance Health shares in Q1 2023, an estimated $221K.
  • Noesis Capital Mangement first reported a position in Elevance Health in Q4 2022 and held it in 1 quarter.
  • Noesis Capital Mangement's Elevance Health position peaked at $221K in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Noesis Capital Mangement's 13F filing for Q1 2023, filed 8 May 2023.